
BeOne Medicines
About
BeOne Medicines is a global oncology company focused on discovering, developing, and commercializing innovative cancer treatments. They have a broad pipeline across hematologic malignancies and solid tumors, utilizing internal research and collaborations. The company aims to make transformative medicines more accessible to patients worldwide.
Key facts
- Website
- beonemedicines.com
- Headquarters
- Basel, Switzerland
- Portfolio companies
- 1
- Cheque size
- $108M to $108M
- Sector focus
- OncologyBiotechnologyPharmaceuticals
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 15 Apr 2026 | Terremoto Biosciences | Series C | $108M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Write the first review
Frequently asked
What companies has BeOne Medicines invested in?
BeOne Medicines has invested in Terremoto Biosciences.
SEC filings, insider activity, nonprofit links and pay benchmarks for BeOne Medicines:

